ALSTON & BIRD LLP for NOVARTIS CORPORATION
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug policy, including reimbursement.
Foreign entity interest: To the extent that Novartis Corporation derives any benefit from legislative or executive action, so, too, does its parent corporation, Novartis AG.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER L BUTLER | — |
| STEPHANIE CURTIS | — |
| Y. BRIAN LEE | — |
| MARK RAYDER | — |
Medicare/Medicaid MMM
Issues related to drug policy, including reimbursement.
Foreign entity interest: To the extent that Novartis Corporation derives any benefit from legislative or executive action, so, too, does its parent corporation, Novartis AG.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER L BUTLER | — |
| STEPHANIE CURTIS | — |
| Y. BRIAN LEE | — |
| MARK RAYDER | — |
Medical/Disease Research/Clinical Labs MED
Issues related to drug policy, including reimbursement.
Foreign entity interest: To the extent that Novartis Corporation derives any benefit from legislative or executive action, so, too, does its parent corporation, Novartis AG.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER L BUTLER | — |
| STEPHANIE CURTIS | — |
| Y. BRIAN LEE | — |
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.